Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 073685109 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
American Century Investment Management, Inc.
13G/A
Amendment 1
|
1.8% |
5/15/2025
Event 3/31/2025
|
|
| American Century Investment Management, Inc. | 1.8% | ||
| American Century Companies, Inc. | 1.8% | ||
| Stowers Institute for Medical Research | 1.8% | ||
| Boston Partners 13G/A Amendment 2 | 4.1% |
5/12/2025
Event 3/31/2025
|
|
| Vanguard Group Inc 13G/A Amendment 13 | 8.4% |
4/30/2025
Event 3/31/2025
|
|
| BlackRock, Inc. 13G/A Amendment 16 | 6.6% |
4/24/2025
Event 3/31/2025
|
|
|
FMR LLC
13G/A
Amendment 7
|
2.2% |
4/7/2025
Event 3/31/2025
|
|
| FMR LLC | 2.2% | ||
| Abigail P. Johnson | 2.2% | ||
| T. Rowe Price Investment Management, Inc. 13G/A Amendment 2 | 3.6% |
2/14/2025
Event 12/31/2024
|
|
| Boston Partners 13G/A Amendment 1 | 7.0% |
2/14/2025
Event 12/31/2024
|
|
|
FMR LLC
13G/A
Amendment 6
|
8.0% |
2/12/2025
Event 12/31/2024
|
|
| FMR LLC | 8.0% | ||
| Abigail P. Johnson | 8.0% | ||
| BlackRock, Inc. 13G/A Amendment 15 | 8.7% |
2/5/2025
Event 12/31/2024
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2025 Q2 | 3 | 3.48 k | $322 k |
| 2025 Q1 | 379 | 58.4 M | $7.23 B |
| 2024 Q4 | 349 | 60.0 M | $6.10 B |
| 2024 Q3 | 325 | 61.0 M | $5.28 B |
| 2024 Q2 | 327 | 62.0 M | $5.61 B |
| 2024 Q1 | 331 | 64.9 M | $6.36 B |
| 2023 Q4 | 335 | 65.2 M | $5.67 B |
| 2023 Q3 | 277 | 63.2 M | $4.88 B |
| 2023 Q2 | 252 | 64.8 M | $5.37 B |
| 2023 Q1 | 249 | 66.9 M | $3.92 B |
| 2022 Q4 | 245 | 67.1 M | $3.55 B |
| 2022 Q3 | 235 | 66.6 M | $3.64 B |
| 2022 Q2 | 241 | 69.7 M | $3.58 B |
| 2022 Q1 | 217 | 72.2 M | $4.28 B |
| 2021 Q4 | 224 | 72.2 M | $4.14 B |
| 2021 Q3 | 209 | 71.9 M | $3.44 B |
| 2021 Q2 | 212 | 71.2 M | $3.79 B |
| 2021 Q1 | 218 | 70.7 M | $3.70 B |
| 2020 Q4 | 223 | 75.0 M | $3.02 B |
| 2020 Q3 | 194 | 70.3 M | $2.18 B |
| 2020 Q2 | 172 | 70.7 M | $1.87 B |
| 2020 Q1 | 159 | 71.2 M | $1.19 B |
| 2019 Q4 | 184 | 71.9 M | $2.30 B |
| 2019 Q3 | 188 | 72.4 M | $2.43 B |
| 2019 Q2 | 209 | 75.2 M | $2.77 B |
| 2019 Q1 | 224 | 79.3 M | $2.55 B |
| 2018 Q4 | 236 | 78.4 M | $2.49 B |
| 2018 Q3 | 258 | 78.5 M | $2.84 B |
| 2018 Q2 | 273 | 76.8 M | $3.27 B |
| 2018 Q1 | 278 | 67.8 M | $3.60 B |
| 2017 Q4 | 296 | 68.1 M | $4.34 B |
| 2017 Q3 | 233 | 69.1 M | $3.54 B |
| 2017 Q2 | 203 | 61.1 M | $3.00 B |
| 2017 Q1 | 214 | 60.7 M | $10.8 B |
| 2016 Q4 | 229 | 61.4 M | $2.83 B |
| 2016 Q3 | 236 | 62.0 M | $2.61 B |
| 2016 Q2 | 253 | 62.2 M | $2.83 B |
| 2016 Q1 | 218 | 63.8 M | $2.62 B |
| 2015 Q4 | 206 | 61.7 M | $2.54 B |
| 2015 Q3 | 177 | 52.0 M | $1.69 B |
| 2015 Q2 | 153 | 53.2 M | $1.77 B |
| 2015 Q1 | 153 | 54.1 M | $1.70 B |
| 2014 Q4 | 147 | 53.8 M | $1.50 B |
| 2014 Q3 | 155 | 54.9 M | $1.40 B |
| 2014 Q2 | 173 | 55.4 M | $1.83 B |
| 2014 Q1 | 168 | 54.1 M | $2.09 B |